NCT00397488View on ClinicalTrials.gov

Sunitinib in Treating Patients With Progressive Metastatic Transitional Cell Cancer of the Urothelium

PHASE2CompletedINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions
Bladder CancerTransitional Cell Cancer of the Renal Pelvis and UreterUrethral Cancer
Interventions
DRUG

sunitinib malate

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Pfizer

INDUSTRY

lead

Memorial Sloan Kettering Cancer Center

OTHER